For Women with Perinatal Mood and Anxiety Disorders, Can Nurses and Midwives Fill the Gaps in Mental Health Care?
Psychological interventions provided by nurses and midwives can significantly reduce the severity of perinatal depressive symptoms.
Essential Reads: Bright Light Therapy for the Treatment of Depression During Pregnancy, Mixed Findings
In terms of the efficacy of bright light therapy for depression during pregnancy, the jury is still out.Â
NPR’s 1A Live Discusses Perinatal Depression and the New Medication Zuranolone
NPR’s 1A Live hosts an episode focusing on perinatal depression, including information on the new medication zuranolone for the treatment of postpartum depression.Â
Essential Reads: Zuranolone for Postpartum Depression
Zuranolone has antidepressant effects in women with severe PPD, observed as early as 3 days after initiation of treatment. Â
Essential Reads: Strategies for the Prevention of Postpartum Depression
Postpartum depression (PPD) is a relatively common problem, affecting between 10% and 15% of women after delivery. Although it is difficult to reliably predict which women in the general population will experience postpartum depression, it [...]
Essential Reads: Using Neuroimaging to Visualize the Impact of Maternal Depression on the Developing Brain
When a woman comes in for a consultation regarding the use of medications during pregnancy, we spend most of our time reviewing the potential risks of exposure to medications during pregnancy. However, we must also [...]
Reproductive psychiatry in 2021: Old questions and new challenges
Dr. Lee S. Cohen recently shared his insights on the practice of reproductive psychiatry during the COVID-19 pandemic with ObGyn News
Treating insomnia, anxiety in a pandemic
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on treating insomnia and anxiety during pregnancy amidst the COVID-19 pandemic with Ob.Gyn News [...]
Is Suicidality on the Rise in Pregnant and Postpartum Women?
Suicide is a leading cause of maternal mortality in the United States. According to a 2017 study from California, drug-related deaths (3.68 per 100,000 person-years) and suicides (1.42 per 100,000 person-years) accounted for nearly [...]
More Data on the Neuroactive Steroid Zuranolone for Postpartum Depression
While we have heard a lot about brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant – SAGE 217 or zuranolone – has been [...]